Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Myriad Genetics Inc (MYGN)  
$17.98 0.65 (3.49%) as of 4:30 Thu 4/25


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 94,542,000
Market Cap: 1.70(B)
Last Volume: 582,160 Avg Vol: 690,780
52 Week Range: $13.91 - $23.73
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Diagnostic Substances

Member Indexes:
    NASDAQ BIOTECHNOLOGY     NASDAQ COMPOSITE
    NASDAQ NNM COMPOSITE

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  618
Guru Rank Value     : 3
Guru Occurances    : 1

 

            6 Months   1 Year   2 Year  
 
Company Profile   Myriad Genetics is precision medicine company acting as an advisor to transform patient lives through molecular diagnostics. Co.'s molecular diagnostic tests are designed to analyze genes, their expression levels and corresponding proteins to assess an individual's risk for developing disease later in life, diagnose disease, determine a patient's likelihood of responding to a particular drug, or disease recurrence and assess a patient's risk of disease progression. Co. also provides biomarker discovery and pharmaceutical and clinical services to the pharmaceutical, biotechnology, and medical research industries utilizing its multiplexed immunoassay technology.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 0 30,000 38,638 109,679
Total Sell Value $0 $572,835 $771,595 $2,187,775
Total People Sold 0 1 2 3
Total Sell Transactions 0 1 2 9
End Date 2024-01-25 2023-10-24 2023-04-25 2022-04-25

   
Records found: 1303
  Page 8 of 53  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Lambert Nicole See Remarks   •       –      –    2021-12-08 4 A $0.00 $0 D/D 10,000 174,486     -
   Wong Pamela Chief Legal Officer   •       –      –    2021-10-18 4 A $0.00 $0 D/D 15,753 15,753     -
   Hart Jayne B. Chief People Officer   •       –      –    2021-10-09 4 D $30.88 $152,115 D/D (4,926) 146,215     -
   Riggsbee Richard Bryan Chief Financial Officer   •       –      –    2021-10-09 4 D $30.88 $382,850 D/D (12,398) 356,765     -
   Verratti Mark President, Myriad Neuroscience   •       –      –    2021-10-09 4 D $30.88 $257,539 D/D (8,340) 194,019     -
   Lanchbury Jerry S Chief Scientific Officer   •       –      –    2021-10-09 4 D $30.88 $333,844 D/D (10,811) 264,324     -
   Haas Kevin Richard Chief Technology Officer   •       –      –    2021-10-09 4 D $30.88 $53,392 D/D (1,729) 53,173     -
   Lambert Nicole See Remarks   •       –      –    2021-10-09 4 D $30.88 $385,475 D/D (12,483) 164,169     -
   Lambert Nicole See Remarks   •       –      –    2021-10-01 4 AS $31.57 $44,835 D/D (1,420) 176,652 -18%     
   Lambert Nicole See Remarks   •       –      –    2021-09-27 4 AS $33.10 $334,747 D/D (10,112) 178,072 -21%     
   Haas Kevin Richard Chief Technology Officer   •       –      –    2021-09-26 4 D $33.31 $28,813 D/D (865) 54,902     -
   Hart Jayne B. Chief People Officer   •       –      –    2021-09-26 4 D $33.31 $73,815 D/D (2,216) 110,120     -
   Verratti Mark President, Myriad Neuroscience   •       –      –    2021-09-26 4 D $33.31 $117,051 D/D (3,514) 202,359     -
   Lanchbury Jerry S Chief Scientific Officer   •       –      –    2021-09-26 4 D $33.31 $121,015 D/D (3,633) 275,135     -
   Riggsbee Richard Bryan Chief Financial Officer   •       –      –    2021-09-26 4 D $33.31 $151,261 D/D (4,541) 369,163     -
   Lambert Nicole See Remarks   •       –      –    2021-09-26 4 D $33.31 $114,120 D/D (3,426) 188,184     -
   Haas Kevin Richard Chief Technology Officer   •       –      –    2021-09-25 4 D $33.31 $11,525 D/D (346) 55,767     -
   Hart Jayne B. Chief People Officer   •       –      –    2021-09-25 4 D $33.31 $129,176 D/D (3,878) 112,336     -
   Verratti Mark President, Myriad Neuroscience   •       –      –    2021-09-25 4 D $33.31 $224,709 D/D (6,746) 205,873     -
   Lanchbury Jerry S Chief Scientific Officer   •       –      –    2021-09-25 4 D $33.31 $324,673 D/D (9,747) 278,768     -
   Riggsbee Richard Bryan Chief Financial Officer   •       –      –    2021-09-25 4 D $33.31 $396,622 D/D (11,907) 373,704     -
   Lambert Nicole See Remarks   •       –      –    2021-09-25 4 D $33.31 $43,669 D/D (1,311) 191,610     -
   Lanchbury Jerry S Chief Scientific Officer   •       –      –    2021-09-23 4 AS $35.06 $7,012 D/D (200) 288,515 -29%     
   Diaz Paul J President and CEO   •       •      –    2021-09-23 4 D $34.76 $1,716,796 D/D (49,390) 796,098     -
   Diaz Paul J President and CEO   •       •      –    2021-09-23 4 A $0.00 $0 D/D 445,439 845,488     -
  1303 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 8 of 53
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us